dexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant]
- RxCUI
- 902624
- RxNorm name
- dexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant]
- Display name
- dexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant]
- Full name
- dexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:09
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexilant | DEXLANSOPRAZOLE | Takeda Pharmaceuticals America, Inc. | 9819f033-3bbe-442e-8e92-45fec77b237d | 2025-02-17 | Warnings, Adverse reactions | 902624 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9819f033-3bbe-442e-8e92-45fec77b237d | Dexilant 30 MG Delayed Release Oral Capsule [PSN] · dexlansoprazole 30 MG Delayed Release Oral Capsule [Dexilant] [SBD] · Dexilant 30 MG Delayed Release Oral Capsule [SY] | 3 | 40 | These highlights do not include all the information needed to use DEXILANT ® safely and effectively. See full prescribing information for DEXILANT. DEXILANT (dexlansoprazole) delayed-release capsules, for oral use Initial U.S. Approval: 1995 (lansoprazole) | 20250217 |